Zenas BioPharma, Inc. (ZBIO) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sr One Capital Management, LLC entity

10% owner

$40.40M (5)

—

+$40.40M

1,917,895

2.94%

$32.37M

—

Jason Raleigh Nunn

Director

$16.20M (3)

—

+$16.20M

1,173,395

1.80%

$19.81M

—

Enavate Sciences GP, LLC entity

10% owner

$15.00M (1)

—

+$15.00M

3,761,359

5.77%

$63.49M

—

Fairmount Funds Management LLC entity

Director

$14.11M (3)

—

+$14.11M

2,359,025

3.62%

$39.82M

+719.3%

Patrick G Enright

Director

$9.73M (3)

—

+$9.73M

1,844,659

2.83%

$31.14M

—

Hongbo Lu

Director

$9.15M (6)

—

+$9.15M

422,968

0.6490%

$7.14M

—

Leon O Moulder Jr

See Remarks

$7.93M (19)

—

+$7.93M

520,083

0.7980%

$8.78M

—

Patricia L Allen

Director

$499.75K (4)

—

+$499.75K

19,860

0.0305%

$335.24K

—

Ting Xiao

Director

$77.60K (1)

—

+$77.60K

47,000

0.0721%

$793.36K

+27.0%

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

10% owner

—

801,624

1.23%

$13.53M

—

Jennifer A. Fox

See Remarks

—

1,592

0.0024%

$26.87K

—

Joseph L Farmer

See Remarks

—

974

0.0015%

$16.44K

—

Zenas BioPharma, Inc.

What the insiders did Net buying

By person